A study in the American Journal of Human Genetics finds that people whose traits diverge from polygenic predictions carry a higher burden of rare, damaging gene variants. The finding reshapes how researchers think about inherited disease risk.
A single number is rarely the whole story. Polygenic scores — tools that estimate a person's risk for a given trait by summing the effects of thousands of common genetic variants — have become central to modern disease research. But for some individuals, the score and the reality don't match. A study published in the American Journal of Human Genetics investigated exactly that gap.
Researchers focused on people whose measured traits deviate meaningfully from what their polygenic score would predict. The study found that these individuals are significantly enriched for rare, damaging variants in genes already linked to rare disease. In other words, when the population-level prediction fails a specific person, a rarer genetic force is often at work.
The research team described this as a "misalignment framework" — a way of identifying individuals where common and rare variant effects appear to pull in opposite directions. According to the study, this pattern is consistent with a liability threshold model of disease, in which the threshold for expressing a condition can be reached by different combinations of genetic factors, not just the common ones that polygenic scores are built to detect.
What this means for complex disease research
Polygenic scores are widely used to stratify populations by risk, guiding everything from clinical trials to preventive care recommendations. The study's authors argued, however, that the individuals most likely to be missed by these tools — those sitting in the gap between predicted and observed traits — may carry the most informative genetic signals for understanding disease architecture.
The findings suggest that rare, damaging variants are not simply background noise in complex trait genetics. They can actively counteract or amplify the cumulative weight of common variants, shifting an individual's outcome in ways the score alone cannot capture.
For the albinism community, this line of research carries a particular resonance. Albinism is caused by variants in specific genes — OCA2, TYR, TYRP1, and others — that are rare in most populations. As polygenic approaches become more embedded in dermatology, ophthalmology, and broader genomic medicine, understanding where rare variants fit within these frameworks matters. The study does not address albinism directly, but its core finding — that rare variant burden explains individual divergence from population prediction — is directly relevant to any community whose genetics sit at the edge of standard models.
The researchers described the misalignment framework as "a powerful tool to explore complex disease architecture," according to the published paper. Whether that tool reaches clinical settings, and whose genetics it is calibrated to represent, remains an open question.
The study was published in the American Journal of Human Genetics.
Keywords
Core topics and entities mentioned in this summary.